GRFS News and Press, Grifols S.A. From 10/06/25

2025-10-06 13:29:00 ET On September 17 , the Fed began cutting interest rates again, which historically preceded Big Pharma's increased activity in the M&A space.... Read the full article on Seeking Alpha For further details see: My Top 5 Biotech Stocks Big Pharm...

2025-10-02 21:23:20 ET I've been covering Grifols (GRFS) for over 2 years. While I initially started out somewhat more dubious, what the company has done over the past few quarters, and over the last annual, reinforces my investment thesis from my previous article .... Read the fu...

2025-08-01 02:55:03 ET More on Grifols, S.A. Grifols, S.A. (GRFS) Q1 2025 Earnings Conference Call Transcript Grifols, S.A. 2025 Q1 - Results - Earnings Call Presentation Historical earnings data for Grifols, S.A. Financial information for Grifols, S.A. ...

AstraZeneca PLC (AZN) is expected to report $1.09 for Q2 2025 Commvault Systems Inc. (CVLT) is expected to report $0.47 for Q1 2026 Ares Capital Corporation (ARCC) is expected to report $0.51 for Q2 2025 Northwest Bancshares Inc. (NWBI) is expected to report $0.29 for Q2 2025 Repl...

2025-07-18 07:05:40 ET We return to Grifols ( GRFS ) with a fresh review, following our previously neutral stance, which reflected a balance of encouraging progress and lingering concerns. As a reminder, we reported many question marks , and even if the company's leverage an...

2025-05-30 12:29:55 ET More on Grifols, S.A. Grifols, S.A. (GRFS) Q1 2025 Earnings Conference Call Transcript Grifols, S.A. 2025 Q1 - Results - Earnings Call Presentation Grifols: A Market Setback Turns Into Buying Opportunity Grifols denies another takeover ...

2025-05-22 12:09:37 ET Summary Grifols offers compelling long-term upside, with potential returns exceeding 200% as the company recovers and grows earnings. Recent Q1 2025 results confirm strong operational recovery: top-line growth, improved margins, and significant debt reductio...

2025-05-13 10:36:52 ET More on Grifols S.A. Grifols, S.A. (GRFS) Q1 2025 Earnings Conference Call Transcript Grifols, S.A. 2025 Q1 - Results - Earnings Call Presentation Grifols: A Market Setback Turns Into Buying Opportunity Grifols denies another takeover f...

2025-05-12 16:51:03 ET Grifols, S.A. (GRFS) Q1 2025 Earnings Conference Call May 12, 2025, 12:30 PM ET Company Participants Danny Segarra - VP, IR and Sustainability Nacho Abia - CEO Rahul Srinivasan - CFO Roland Wandeler - President Biopharma ...

2025-04-23 11:10:00 ET Summary Grifols, a Spanish multinational specializing in plasma-derived therapies, is undervalued due to historical mismanagement but holds a strong market position with significant competitive advantages. New management has implemented an operational improv...